Clinical Trial

Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the feasibility of combining IV ketamine, a rapid acting antidepressant, with a course of Mindfulness-Based Cognitive Therapy (MBCT), for the initial and maintenance treatment of depression.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-10.
Status change: Recruiting → Active, Not Recruiting 2025-08-07
Trial Details
NCT Number NCT05950711
Lead Sponsor Ohio State University
Conditions Major Depressive Disorder
Enrollment 21 participants
Start Date 2022-03-30
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-11